*ST科陸(002121.SZ)擬向玉門新能源增資8000萬元
格隆匯 7 月 22日丨*ST科陸(002121.SZ)公佈,公司第七屆董事會第二十一次(臨時)會議審議通過了《關於向全資子公司增資的議案》,同意公司向全資子公司玉門市科陸新能源有限公司(“玉門新能源”)增資人民幣8000萬元,此次增資完成後,玉門新能源註冊資本由人民幣2000萬元增加至人民幣1億元。
公司此次向玉門新能源增資有利於改善玉門新能源資產負債結構,使得後續的處置剝離更具可行性,符合公司“聚焦核心主業,剝離非核心業務資產”的整體發展戰略。玉門新能源增資完成後,仍為公司全資子公司,不影響公司合併報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.